Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
DiabetesDementiaHypoglycemia; Drug
Interventions
BEHAVIORAL

STRIDE

a. Targeted providers for STRIDE program: i. Clinical staff at the LTCF who participate in deprescribing at the facilities (physicians (MDs), physician's assistants (PAs), nurse practitioners (NPs), clinical pharmacists): clinical staff members caring for LTCF residents with ADRD and diabetes at 6 LTCFs in the Ohio and Michigan areas will be invited via email from the LTCF leadership to participate in the STRIDE education program. The STRIDE program consist of practical algorithms and educational material, which they are free to view at any time, and participation in 2 webinars and monthly telementoring calls

Trial Locations (1)

02215

Joslin Diabetes Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brown University

OTHER

collaborator

Theoria Medical

UNKNOWN

lead

Joslin Diabetes Center

OTHER